ANI Pharmaceuticals Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
ANI Pharma (ANIP) Tops Q2 EPS by 16c, Updates Guidance
August 7, 2019 8:34 AM EDTANI Pharma (NASDAQ: ANIP) reported Q2 EPS of $1.44, $0.16 better than the analyst estimate of $1.28. Revenue for the quarter came in at $54.4 million versus the consensus estimate of $55.2 million.
GUIDANCE:
ANI Pharma sees FY2019 EPS of $5.57-$6.21, versus the consensus... More
